The current JANX market cap is 2.57B. The company's latest EPS is USD -1.1284 and P/E is -43.96.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.81M | 2.85M | 2.05M | 1.06M | 2.52M |
Operating Income | -18.02M | -18.27M | -20.28M | -20.75M | -15.81M |
Net Income | -16.7M | -16.07M | -17.46M | -17.51M | -11.57M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 3.64M | 8.61M | 8.08M |
Operating Income | -3.77M | -4.84M | -32.93M | -67.09M | -72.98M |
Net Income | -4M | -6.78M | -32.67M | -63.06M | -58.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 375.76M | 364.01M | 352.96M | 341.5M | 386.85M |
Total Liabilities | 44.24M | 43.27M | 41.69M | 42.03M | 37.9M |
Total Equity | 331.51M | 320.74M | 311.26M | 299.47M | 348.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 679k | 16.22M | 379.82M | 364.01M | 380.41M |
Total Liabilities | 4.63M | 9.23M | 13.5M | 43.27M | 36.06M |
Total Equity | -7.94M | -14.64M | 366.33M | 320.74M | 344.35M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -31.01M | -42.92M | -13.91M | -28.97M | -40.67M |
Investing | 59.87M | 58.27M | -8.74M | 9.13M | -52.32M |
Financing | 309k | 500k | 1.58M | 2.11M | 58.72M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.83M | -4.37M | -16.98M | -42.92M | -50.58M |
Investing | N/A | N/A | -340.96M | 58.27M | -41.19M |
Financing | 4M | 11.52M | 386.52M | 500k | 59.55M |
Market Cap | 2.57B |
Price to Earnings Ratio | -43.96 |
Price to Sales Ratio | 317 |
Price to Cash Ratio | 133.43 |
Price to Book Ratio | 7.44 |
Dividend Yield | - |
Shares Outstanding | 51.66M |
Average Volume (1 week) | 667.2k |
Average Volume (1 Month) | 830.74k |
52 Week Change | 219.72% |
52 Week High | 58.6936 |
52 Week Low | 5.65 |
Spread (Intraday) | 2.65 (5.16%) |
Company Name | Janux Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.januxrx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.